Tracking the healing of chronic venous leg ulcers with a special foam dressing
Official title: A Prospective, Open, Multi-Center, Interventional, Non-Comparative Clinical Investigation to Follow the Progress of Exuding Venous Leg Ulcers Using a Non-Bordered Foam Dressing
Run by Molnlycke Health Care AB · NCT05608317 · Data updated 2026-11-12
This study is testing a special foam dressing to see if it helps people with chronic venous leg ulcers heal better over six weeks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Molnlycke Health Care AB Industry-sponsored |
| Locations | 3 sites (San Francisco, California and 2 other locations) |
| Status | Recruiting |
| Started | November 8, 2022 |
| Main results expected | July 30, 2024 |
| Study ends | November 30, 2024 |
| Registry record updated | May 6, 2024 |
| Trial ID | NCT05608317 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with chronic, exuding venous leg ulcers that meet specific size and exudate criteria.
✕Probably not a fit
Patients with infected ulcers or known allergies to the dressing materials may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical investigation aims to monitor the healing process of chronic venous leg ulcers (VLUs) using a non-bordered foam dressing over a period of up to six weeks. Participants will wear the dressing, which will be changed weekly, while their wound progress is assessed through objective measurements and subjective evaluations of pain, comfort, and quality of life. The study will involve multiple visits to the investigation site to ensure thorough monitoring and safety assessments. A total of 20 participants will be recruited across six centers in the US and Canada.
Why it matters
Potential benefit: If successful, this study could improve healing outcomes for patients with chronic venous leg ulcers.
How similar studies have gone: While similar approaches have been explored, this specific investigation focuses on a novel dressing type for chronic venous leg ulcers.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signed consent to participate (including consent for digital imaging) * Adult aged ≥18 years * Diagnosed with a chronic, exuding VLU * Exudate amount moderate to large * Wound size from 3 cm2 to 30 cm2, as determined by the clinician * ABPI (within 3 months) \> 0.7. If ABPI \> 1.4, then big toe pressure \> 60 mmHg is required or an alternative measurement verifying normal distal arterial flow * Willing to be compliant with compression therapy Exclusion Criteria: * Infected ulcer according to the judgment of the investigator defined as any wound condition requiring the prescription or continuation of systemic antibiotic therapy at enrollment * Circumferential wound * Known allergy/hypersensitivity to the materials of the dressing * Use of wound fillers
Where it's running
-
University of Miami
Miami, Florida, United States Recruiting -
Serena Group Research Institute
Pittsburgh, Pennsylvania, United States Recruiting -
Center for Clinical Trials, Inc.
San Francisco, California, United States Not yet recruiting
Study contacts
- Principal investigator: Hadar Lev-Tov, MD, MAS — University of Miami
- Study coordinator: Janet Kandrevas, MD, MS
- Email: janet.kandrevas@molnlycke.com
- Phone: 734-358-2174
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tracking the healing of chronic wounds with a special dressing
This study is testing a special dressing called Mepilex Up to see if it helps people with chronic wounds, like venous leg ulcers and diabetic foot ulcers, heal better over six weeks.
-
Tissue Repair Gel for treating Venous Leg Ulcers
This study is testing a new gel to see if it helps people with stubborn leg ulcers heal better when used with standard treatment compared to standard treatment alone.
-
4-aminopyridine for faster skin wound healing
This trial will see if 4-aminopyridine helps small skin wounds heal faster in healthy adults aged 18–70.
-
PAW-hydrogel to help chronic wounds like diabetic foot and leg ulcers heal faster
This trial will test whether a plasma-activated water–infused Carbopol® 940 hydrogel helps adults with long-standing wounds (diabetic foot, pressure, venous, arterial, or dehiscent ulcers) heal faster and have less bacteria compared with standard advanced wound care.
-
GORE VIABAHN FORTEGRA Venous Stent Post-Approval Study
This study tests the GORE VIABAHN FORTEGRA Venous Stent in real-world patients with venous diseases to see how it performs after it is approved.
-
Human placental membrane products plus standard care for nonhealing diabetic foot and venous leg ulcers
This trial will try human placental membrane products together with standard wound care to help adults whose diabetic foot ulcers or venous leg ulcers have not healed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.